Artes Medical to Announce Financial Results for the Quarter Ended September
30, 2007
SAN
DIEGO--(BUSINESS WIRE)--Nov. 8, 2007--Artes
Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill(R) is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of "smile line"
wrinkles, announced that it will release its financial results for the quarter
ended September 30, 2007 on Tuesday, November 13, 2007 at 1:30 p.m. Pacific
Time.
Artes
Medical will host a webcast
and conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on
November 13, 2007 to discuss the financial results. The dial in numbers are (866) 700-7477 for domestic
callers, and (617) 213-8840 for international callers. The passcode for both domestic and international callers
is 61763260. A live webcast
of the conference call will be available online from the investor relations
page of the Company's corporate website at www.artesmedical.com. Participating
in the call will be Diane S. Goostree,
President and Chief Executive Officer and Peter C. Wulff, Executive Vice President and Chief Financial
Officer.
After the live web cast the call will remain
available on Artes Medical's web site for at least
30 days following presentation. In addition, a telephonic reply of the call
will be available for 7 days. The replay dial-in numbers are (888) 286-8010 for
domestic callers, and (617)
801-6888 for international callers. The passcode
for both domestic and international callers is 81923092.
About Artes
Medical, Inc.
Artes Medical
is a medical technology company focused on developing, manufacturing and
commercializing a new category of aesthetic injectable products for the dermatology and plastic
surgery markets. The Company's initial product, ArteFill, is
being marketed to men and women as a treatment option for the
correction of nasolabial
folds. There were approximately two million dermal filler procedures in the
Artes
Medical(R) and ArteFill(R)
are registered trademarks of Artes
Medical, Inc.
CONTACT: Artes Medical, Inc.
Cheryl Monblatt Allen,
858-550-9999 (Investor Relations)
callen@artesmedical.com or
Schwartz Communications, Inc.
Thea Lavin, 415-512-0770 (Corporate Media)
artes@schwartz-pr.com
SOURCE: Artes Medical, Inc.